While it was reported that elevated EPO levels are associated with poor survival in heart failure, diabetic chronic kidney disease (CKD), and kidney transplant recipients9–11, its impact on renal outcomes remains to be determined. This evidence concerns the gene EPO and chronic kidney disease.